Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$27.8 - $45.35 $556,000 - $907,000
20,000 Added 2.29%
893,763 $38.9 Million
Q2 2023

Aug 08, 2023

BUY
$36.13 - $49.49 $3.96 Million - $5.42 Million
109,498 Added 14.33%
873,763 $31.6 Million
Q1 2023

May 12, 2023

SELL
$36.54 - $54.26 $121,714 - $180,740
-3,331 Reduced 0.43%
764,265 $28.4 Million
Q4 2022

Feb 13, 2023

BUY
$41.27 - $98.62 $4.34 Million - $10.4 Million
105,095 Added 15.86%
767,596 $34.8 Million
Q3 2022

Nov 10, 2022

BUY
$59.5 - $86.7 $4.06 Million - $5.91 Million
68,217 Added 11.48%
662,501 $46.3 Million
Q2 2022

Aug 03, 2022

BUY
$39.16 - $88.71 $3.43 Million - $7.76 Million
87,511 Added 17.27%
594,284 $39.9 Million
Q1 2022

May 13, 2022

BUY
$75.82 - $150.97 $1.08 Million - $2.16 Million
14,290 Added 2.9%
506,773 $41.7 Million
Q4 2021

Feb 10, 2022

BUY
$132.01 - $190.29 $14.4 Million - $20.8 Million
109,264 Added 28.51%
492,483 $72.2 Million
Q3 2021

Nov 09, 2021

BUY
$132.13 - $177.45 $4.97 Million - $6.68 Million
37,623 Added 10.89%
383,219 $67.8 Million
Q2 2021

Jul 20, 2021

BUY
$144.0 - $179.73 $22.5 Million - $28.1 Million
156,496 Added 82.76%
345,596 $55.8 Million
Q1 2021

Apr 29, 2021

BUY
$158.92 - $221.61 $317 - $443
2 Added 0.0%
189,100 $39.9 Million
Q4 2020

Jan 22, 2021

BUY
$162.05 - $240.27 $9.07 Million - $13.4 Million
55,961 Added 42.03%
189,098 $41.5 Million
Q3 2020

Oct 19, 2020

BUY
$113.26 - $167.27 $2.61 Million - $3.86 Million
23,076 Added 20.97%
133,137 $22.1 Million
Q2 2020

Jul 23, 2020

BUY
$72.01 - $120.39 $772,883 - $1.29 Million
10,733 Added 10.81%
110,061 $12.6 Million
Q1 2020

May 26, 2020

BUY
$69.78 - $116.21 $348 - $581
5 Added 0.01%
99,328 $12.5 Million
Q4 2019

Jan 21, 2020

SELL
$70.76 - $128.86 $1.63 Million - $2.96 Million
-22,977 Reduced 18.79%
99,323 $13,000
Q3 2019

Oct 21, 2019

SELL
$77.91 - $109.6 $2.7 Million - $3.8 Million
-34,700 Reduced 22.1%
122,300 $10,000
Q2 2019

Aug 01, 2019

BUY
$59.49 - $104.71 $2.62 Million - $4.61 Million
44,000 Added 38.94%
157,000 $16.1 Million
Q1 2019

May 02, 2019

SELL
$43.65 - $78.95 $4.28 Million - $7.74 Million
-98,000 Reduced 46.45%
113,000 $8.28 Million
Q4 2018

Feb 14, 2019

BUY
$32.0 - $47.43 $608,000 - $901,170
19,000 Added 9.9%
211,000 $8.95 Million
Q3 2018

Nov 07, 2018

BUY
$47.1 - $62.7 $4.68 Million - $6.23 Million
99,300 Added 107.12%
192,000 $9.04 Million
Q2 2018

Aug 14, 2018

BUY
$26.05 - $52.4 $2.41 Million - $4.86 Million
92,700 New
92,700 $4.57 Million

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.